Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yasuhiro Masubuchi & Toshiharu Horie. (2007) Toxicological Significance of Mechanism-Based Inactivation of Cytochrome P450 Enzymes by Drugs. Critical Reviews in Toxicology 37:5, pages 389-412.
Read now
Read now
N. Ishiguro, C. Senda, W. Kishimoto, K. Sakai, Y. Funae, T. Igarashi. (2000) Identification of CYP3A4 as the predominant isoform responsible for the metabolism of ambroxol in human liver microsomes. Xenobiotica 30:1, pages 71-80.
Read now
Read now
W. TASSANEEYAKUL, D. J. BIRKETT & J. O. MINERS*. (1998) Inhibition of human hepatic cytochrome P4502E1 by azole antifungals, CNS-active drugs and nonsteroidal anti-inflammatory agents. Xenobiotica 28:3, pages 293-301.
Read now
Read now
O. PELKONEN, J. MÄEENPÄEÄ, P. TAAVITSAINEN, A. RAUTIO & H. RAUNIO. (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:12, pages 1203-1253.
Read now
Read now
D. A. SMITH, S. M. ABEL, R. HYLAND & B. C. JONES. (1998) Human cytochrome P450s: selectivity and measurement in vivo. Xenobiotica 28:12, pages 1095-1128.
Read now
Read now
Bernard Testa. (1990) Mechanisms of inhibition of xenobiotic-metabolizing enzymes. Xenobiotica 20:11, pages 1129-1137.
Read now
Read now
Articles from other publishers (64)
N.A. Meanwell. 2017.
245
361
.
Mark Johnson, Shayne Gad & Christopher Kemper. 2015. Animal Models in Toxicology, Third Edition. Animal Models in Toxicology, Third Edition
153
283
.
Angela Dudda & Gert Ulrich Kuerzel. 2013. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays
1053
1094
.
Wolfgang Kromer, Stefan Postius, Uwe Krüger & C. Robin Ganellin. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Ming Tao, Rita Raddatz, Lisa D. Aimone & Robert L. Hudkins. (2011) Synthesis and structure–activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 21:20, pages 6126-6130.
Crossref
Crossref
Dorota Łażewska, Małgorzata Więcek, Xavier Ligneau, Tim Kottke, Lilia Weizel, Roland Seifert, Walter Schunack, Holger Stark & Katarzyna Kieć-Kononowicz. (2009) Histamine H3 and H4 receptor affinity of branched 3-(1H-imidazol-4-yl)propyl N-alkylcarbamates. Bioorganic & Medicinal Chemistry Letters 19:23, pages 6682-6685.
Crossref
Crossref
Stefanie D. Krämer & Bernard Testa. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:10, pages 1477-1660.
Crossref
Crossref
Jill A. Jablonowski, Kiev S. Ly, Michael Bogenstaetter, Curt A. Dvorak, Jamin D. Boggs, Lisa K. Dvorak, Brian Lord, Kirsten L. Miller, Curt Mazur, Sandy J. Wilson, Timothy W. Lovenberg & Nicholas I. Carruthers. (2009) Novel imidazole-based histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters 19:3, pages 903-907.
Crossref
Crossref
Vincent J. Santora, Jonathan A. Covel, Rena Hayashi, Brian J. Hofilena, Jason B. Ibarra, Michelle D. Pulley, Michael I. Weinhouse, Dipanjan Sengupta, Jonathan J. Duffield, Graeme Semple, Robert R. Webb, Carleton Sage, Albert Ren, Guilherme Pereira, Jens Knudsen, Jeffrey E. Edwards, Marissa Suarez, John Frazer, William Thomsen, Erin Hauser, Kevin Whelan & Andrew J. Grottick. (2008) A new family of H3 receptor antagonists based on the natural product Conessine. Bioorganic & Medicinal Chemistry Letters 18:4, pages 1490-1494.
Crossref
Crossref
Luc Roumen, Marijn P. A. Sanders, Koen Pieterse, Peter A. J. Hilbers, Ralf Plate, Erica Custers, Marcel de Gooyer, Jos F. M. Smits, Ilona Beugels, Judith Emmen, Harry C. J. Ottenheijm, Dirk Leysen & J. J. R. Hermans. (2007) Construction of 3D models of the CYP11B family as a tool to predict ligand binding characteristics. Journal of Computer-Aided Molecular Design 21:8, pages 455-471.
Crossref
Crossref
Ping-Kun Chan, Shui-Yuan Lu, Jiunn-Wang Liao, Chung-fan Wei, Yiya Tsai & Tzuu-Huei Ueng. (2006) Induction and inhibition of cytochrome P450-dependent monooxygenases of rats by fungicide bitertanol. Food and Chemical Toxicology 44:12, pages 2047-2057.
Crossref
Crossref
Michael Berlin, Pauline C. Ting, Wayne D. Vaccaro, Robert Aslanian, Kevin D. McCormick, Joe F. Lee, Margaret M. Albanese, Mwangi W. Mutahi, John J. Piwinski, Neng-Yang Shih, Luli Duguma, Daniel M. Solomon, Wei Zhou, Rosy Sher, Leonard Favreau, Matthew Bryant, Walter A. Korfmacher, Cymbelene Nardo, Robert E. WestJr.Jr., John C. Anthes, Shirley M. Williams, Ren-Long Wu, H. Susan She, Maria A. Rivelli, Michel R. Corboz & John A. Hey. (2006) Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 16:4, pages 989-994.
Crossref
Crossref
Wayne D. Vaccaro, Rosy Sher, Michael Berlin, Neng-Yang Shih, Robert Aslanian, John H. Schwerdt, Kevin D. McCormick, John J. Piwinski, Robert E. WestJr.Jr., John C. Anthes, Shirley M. Williams, Ren-Long Wu, H. Susan She, Maria A. Rivelli, Jennifer C. Mutter, Michel R. Corboz, John A. Hey & Leonard Favreau. (2006) Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold. Bioorganic & Medicinal Chemistry Letters 16:2, pages 395-399.
Crossref
Crossref
Angela Dudda & Gert Ulrich Kürzel. 2006. Drug Discovery and Evaluation. Drug Discovery and Evaluation
493
520
.
Yukihiro Matsumoto, Murat Dogru, Eiki Goto, Hiroshi Fujishima & Kazuo Tsubota. (2005) Successful Topical Application of a New Antifungal Agent, Micafungin, in the Treatment of Refractory Fungal Corneal Ulcers. Cornea 24:6, pages 748-753.
Crossref
Crossref
Kiyomi Ito, Kanako Ogihara, Shin-ichi Kanamitsu & Tomoo Itoh. (2003) PREDICTION OF THE IN VIVO INTERACTION BETWEEN MIDAZOLAM AND MACROLIDES BASED ON IN VITRO STUDIES USING HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition 31:7, pages 945-954.
Crossref
Crossref
Donald J. AbrahamBernard Testa & William Soine. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
431
498
.
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
Crossref
T. Miyahara, Y. Tokita & H. Nakatsuji. (2001) SAC/SAC−CI Study of the Ground, Excited, and Ionized States of Cytochromes P450CO. The Journal of Physical Chemistry B 105:30, pages 7341-7352.
Crossref
Crossref
C. NEBBIA. (2001) Biotransformation Enzymes as Determinants of Xenobiotic Toxicity in Domestic Animals. The Veterinary Journal 161:3, pages 238-252.
Crossref
Crossref
Chin‐Eng Ong, Sally Coulter, Donald J. Birkett, C. Ramana Bhasker & John O. Miners. (2008) The xenobiotic inhibitor profile of cytochrome P4502C8. British Journal of Clinical Pharmacology 50:6, pages 573-580.
Crossref
Crossref
E.Olatunde Farombi, Babatunde I Olowu & Godwin O Emerole. (2000) Effect of three structurally related antimalarial drugs on liver microsomal components and lipid peroxidation in rats. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 126:3, pages 217-224.
Crossref
Crossref
Wolfgang Kromer, Stefan Postius & Uwe Krüger. 2000. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
Koji Takeuchi, Akira Konaka, Masato Nishijima, Shinichi Kato & Tetsuya Yasuhiro. (2002) Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: A comparative study with omeprazole and lansoprazole. Journal of Gastroenterology and Hepatology 14:3, pages 251-257.
Crossref
Crossref
Ding Y. Liu & John W. Gorrod. (1999) INDUCTION AND INHIBITION OF THE IN VITRO Ν1-OXIDATION OF 9-BENZYLADENINE AND ISOMERIC 9-(NITROBENZYL)ADENINES. Drug Metabolism and Drug Interactions 15:2-3.
Crossref
Crossref
Nicolas Sennequier, Dennis Wolan & Dennis J. Stuehr. (1999) Antifungal Imidazoles Block Assembly of Inducible NO Synthase into an Active Dimer. Journal of Biological Chemistry 274:2, pages 930-938.
Crossref
Crossref
L. L. Lukash. (1998) Mutagenesis and antimutagenesis are contrary directed processes determining the level of genetic variability and stability. Biopolymers and Cell 14:6, pages 500-511.
Crossref
Crossref
K.M.L. Crommentuyn, J.H.M. Schellens, J.D. van den Berg & J.H. Beijnen. (1998) In-vitro metabolism of anti-cancer drugs, methods and applications: paclitaxel, docetaxel, tamoxifen and ifosfamide. Cancer Treatment Reviews 24:5, pages 345-366.
Crossref
Crossref
Tetsuya Kamataki, Tsuyoshi Yokoi, Ken-ichi Fujita & Yuichi Ando. (1998) Preclinical approach for identifying drug interactions. Cancer Chemotherapy and Pharmacology 42:S1, pages S50-S53.
Crossref
Crossref
Sabine Gernhardt, Elke Karge, Bruno Schönecker & Wolfgang Klinger. (2006) Influence of Various Estrogens on Biotransformation: Affinity to Cytochrome P‐450, Structure Activity Relationships, and Scavenger Function. Archiv der Pharmazie 330:5, pages 135-140.
Crossref
Crossref
Xiaoxiong Wei, Cho-Ming Loi, Douglas L. Schmucker & Robert E. Vestal. (1995) Characterization of the independent and combined effects of two inhibitors on oxidative drug metabolism in rat liver microsomes. Biochemical Pharmacology 49:11, pages 1657-1663.
Crossref
Crossref
Collen M. Masimirembwa & Julia A. Hasler. (1994) Characterisation of praziquantel metabolism by rat liver microsomes using cytochrome P450 inhibitors. Biochemical Pharmacology 48:9, pages 1779-1783.
Crossref
Crossref
C. M. Masimirembwa, Y. S. Naik & J. A. Hasler. (1993) Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics of praziquantel in rats. European Journal of Drug Metabolism and Pharmacokinetics 18:3, pages 261-264.
Crossref
Crossref
David Lalka, Robert K. Griffith & Carol L. Cronenberger. (2013) The Hepatic First‐Pass Metabolism of Problematic Drugs. The Journal of Clinical Pharmacology 33:7, pages 657-669.
Crossref
Crossref
A M NdiforR E HowellsP G BrayJ L NguS A Ward. (1993) Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors. Antimicrobial Agents and Chemotherapy 37:6, pages 1318-1323.
Crossref
Crossref
Robert J. Riley, Sara A. Hemingway, Martin A. Graham & Paul Workman. (1993) Initial characterization of the major mouse cytochrome p450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-Amino-1,2,4-Benzotriazine-1,4-di-N-Oxide (Tirapazamine, SR 4233, Win 59075). Biochemical Pharmacology 45:5, pages 1065-1077.
Crossref
Crossref
Daune L. Crankshaw & Nadia D. Hines. (1992) Hepatic microsomes from beer fed rats contain a cytochrome P-450 metabolic intermediate complex. Biochemical and Biophysical Research Communications 189:2, pages 899-905.
Crossref
Crossref
F.S. LaBella, G. Queen, G. Glavin, G. Durant, D. Stein & L.J. Brandes. (2012)
H
3
receptor antagonist, thioperamide, inhibits adrenal steroidogenesis and histamine binding to adrenocortical microsomes and binds to cytochrome P450
. British Journal of Pharmacology 107:1, pages 161-164.
Crossref
Crossref
Brian Gemzik & Andrew Parkinson. (1992) Hydroxylation of 5α-androstane-3β,17β-diol by rat prostate microsomes: Potent inhibition by imidazole-type antimycotic drugs and lack of inhibition by steroid 5α-reductase inhibitors. Archives of Biochemistry and Biophysics 296:2, pages 366-373.
Crossref
Crossref
Mimi L. Meeks, Kenneth W. Mahaffey & Michael D. Katz. (2016) Danazol Increases the Anticoagulant Effect of Warfarin. Annals of Pharmacotherapy 26:5, pages 641-642.
Crossref
Crossref
D. Catlin, D. Cowan, M. Donike, D. Fraisse, H. Oftebro & S. Rendic. (1992) Testing urine for drugs. Clinica Chimica Acta 207:3, pages S13-S26.
Crossref
Crossref
G. S. Shaimardanova, R. A. Kamburg, R. P. Evstigneeva & N. V. Sergeeva. (1992) Imidazole and its derivatives as biologically active substances. Pharmaceutical Chemistry Journal 26:3, pages 222-231.
Crossref
Crossref
Karl‐Henrik Jönsson & Björn Lindeke. (2004) Cytochrome p‐455 nm complex formation in the metabolism of phenylalkylamines. XII. Enantioselectivity and temperature dependence in microsomes and reconstituted cytochrome p‐450 systems from rat liver. Chirality 4:8, pages 469-477.
Crossref
Crossref
Andrew Parkinson & Aryeh Hurwitz. (1991) Omeprazole and the induction of human cytochrome P-450: A response to concerns about potential adverse effects. Gastroenterology 100:4, pages 1157-1164.
Crossref
Crossref
Julio C. Davila, Patrick J. Davis & Daniel Acosta. (1991) Changes in glutathione and cellular energy as potential mechanisms of papaverine-induced hepatotoxicity in Vitro. Toxicology and Applied Pharmacology 108:1, pages 28-36.
Crossref
Crossref
Craig K. Svensson, Robert K. Drobitch & Kevin A. Kloss. (1991) Effect of Glutathione Depletion on the In Vivo Inhibition of Drug Metabolism by Agents Forming an Inactive Cytochrome P-450 Fe(ll):Metabolite Complex. Studies with Amiodarone and Troleandomycin. Journal of Pharmaceutical Sciences 80:3, pages 225-228.
Crossref
Crossref
David McKillop & Kathryn J. Pickup. (1991) Different inhibition and induction profiles of hepatic drug metabolism in rats and dogs by two structurally related pyridyl diazinone cardiotonic agents. Biochemical Pharmacology 41:3, pages 411-417.
Crossref
Crossref
Silvia Fernandez Villamil, Marta Dubin, Conrado Galeffi & Andr?s O.M. Stoppani. (1990) Effects of mansonones on lipid peroxidation, P450 monooxygenase activity, and superoxide anion generation by rat liver microsomes. Biochemical Pharmacology 40:10, pages 2343-2351.
Crossref
Crossref
Geoffrey C. Farrell & Michael Murray. (1990) Human cytochrome P450 isoforms. Gastroenterology 99:3, pages 885-889.
Crossref
Crossref
D Sesardic, AR Boobis, BP Murray, S Murray, J Segura, R de la Torre & DS Davies. (2012) Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.. British Journal of Clinical Pharmacology 29:6, pages 651-663.
Crossref
Crossref
K.Ashley Milton, Paula E. Hoaksey, Stephen A. Ward & Geoffrey Edwards. (1990) Lack of effect of halofantrine on hepatic drug metabolism in the rat in vivo and in vitro. Biochemical Pharmacology 39:10, pages 1581-1586.
Crossref
Crossref
. (2012) POSTER COMMUNICATIONS. British Journal of Pharmacology 99:S1.
Crossref
Crossref
Marta Dubin, Silvia H.Fernandez Villamil & Andrés O.M. Stoppani. (1990) Inhibition of microsomal lipid peroxidation and cytochrome P-450-catalyzed reactions by β-lapachone and related naphthoquinones. Biochemical Pharmacology 39:7, pages 1151-1160.
Crossref
Crossref
S. Madden, D.J. Back & M.L'E. Orme. (1990) Metabolism of the contraceptive steroid desogestrel by human liver in vitro. Journal of Steroid Biochemistry 35:2, pages 281-288.
Crossref
Crossref
D. Müller. (1990) Influence of xenobiotics on drug metabolism and its sensitive detection. Experimental Pathology 39:3-4, pages 187-194.
Crossref
Crossref
T. Yamano, Y. Tsujimoto, T. Noda, M. Shimizu, M. Ohmori, S. Morita & A. Yamada. (1990) Hepatotoxicity of geniposide in rats. Food and Chemical Toxicology 28:7, pages 515-519.
Crossref
Crossref
Thananda Sukhumanan, Wichitra Suphakawanich & Amnuay Thithapandha. (1990) Comparative inhibitory effects of mefloquine and primaquine on hepatic drug-metabolizing enzymes. Biochemical Pharmacology 39:1, pages 212-216.
Crossref
Crossref
Gordon F. Reidy & Michael Murray. (1990) Evidence for complexation of P-450 IIC6 by an orphenadrine metabolite. Biochemical and Biophysical Research Communications 166:2, pages 772-779.
Crossref
Crossref
Craig K. Svensson & Mok-Thoong Chong. (1989) Effect of Amiodarone on the Disposition of Acetaminophen in the Rat. Journal of Pharmaceutical Sciences 78:11, pages 900-902.
Crossref
Crossref
E. Rekka, H. Timmermann & A. Bast. (1989) Structural features of some diphenhydramine analogues that determine the interaction with rat liver cytochrome P-450. Agents and Actions 27:1-2, pages 184-187.
Crossref
Crossref
C.-B. Bernard, J.T. Arnason, B.J.R. Philogène, J. Lam & T. Waddell. (1989) Effect of lignans and other secondary metabolites of the asteraceae on the mono-oxygenase activity of the european corn borer. Phytochemistry 28:5, pages 1373-1377.
Crossref
Crossref
Shmuel Zbaida, Albert M. Stoddart & Walter G. Levine. (1989) Studies on the mechanism of reduction of azo dye carcinogens by rat liver microsomal cytochrome P-450. Chemico-Biological Interactions 69:1, pages 61-71.
Crossref
Crossref
R. Seyffer, M. Eichelbaum, J. C. Jensen & U. Klotz. (1989) Antipyrine metabolism is not affected by terbinafine, a new antifungal agent. European Journal of Clinical Pharmacology 37:3, pages 231-233.
Crossref
Crossref
E. Rekka, G.J. Sterk, H. Timmerman & A. Bast. (1988) Identification of structural characteristics of some potential H2-receptor antagonists that determine the interaction with rat hepatic P-450. Chemico-Biological Interactions 67:1-2, pages 117-127.
Crossref
Crossref